$DCTH Recent News Delcath cuts work force by 20% 7:07

New Post Public Reply Private Reply Replies (0) Message Board

Jan 22, 2014 at 2:09 PM

$DCTH Recent News

Delcath cuts work force by 20% 7:07 a.m. June 26, 2013 - MarketWatch.com
Friday’s movers: Regeneron, LinkedIn 3:18 p.m. May 3, 2013 - Wallace Witkowski
Delcath Systems falls 11% in premarket 7:22 a.m. Oct. 15, 2012 - Steve Gelsi
Hot stocks to watch 6:39 a.m. Sept. 4, 2012 - MarketWatch.com
Friday’s top gaining and declining stocks 3:33 p.m. May 25, 2012 - Val Brickates Kennedy
Delcath prices stock offering at 37% discount 11:06 a.m. May 25, 2012 - MarketWatch.com
Friday’s biggest gaining and declining stocks 4:10 p.m. Jan. 2, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 4:01 p.m. Jan. 2, 2012 - Kate Gibson
Stocks to watch Tuesday: Boeing, Verizon 12:58 p.m. Dec. 31, 2011 - MarketWatch
TI, Cisco edge up, MoSys slips after-hours 4:33 p.m. Dec. 30, 2011 - Benjamin Pimentel
Delcath reports inconclusive results from trial 11:02 a.m. Sept. 1, 2011 - MarketWatch.com
Friday’s biggest gaining and declining stocks 2:49 p.m. July 15, 2011 - Kate Gibson
Tuesday’s biggest gainers and decliners 4:57 p.m. Feb. 22, 2011 - Kate Gibson
Delcath, Clinical Data lead drug stocks south 3:36 p.m. Feb. 22, 2011 - Val Brickates Kennedy
Delcath implodes on FDA setback 9:57 a.m. Feb. 22, 2011 - Val Brickates Kennedy
In focus: Have the bears arrived? 7:30 p.m. Nov. 10, 2010 - Lawrence G. McMillan
S&P 500 pulls in from the 1,200 resistance 9:46 a.m. Oct. 27, 2010 - Michael Ashbaugh
Market bulls absorb weak Sept. jobs report 9:19 a.m. Oct. 8, 2010 - Michael Ashbaugh
Monday's biggest gaining and declining stocks 3:56 p.m. June 7, 2010 - MarketWatch
Thursday's biggest gaining and declining stocks 4:02 p.m. April 22, 2010 - MarketWatch

Delcath files for reverse split authorization, shares drop 2:19 p.m. Dec. 13, 2013 - Seeking Alpha
Delcath Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule 5:35 a.m. Dec. 13, 2013 - benzinga.com
Delcath Systems' CEO Discusses Q3 2013 Results - Earnings Call Transcript 9:56 p.m. Nov. 6, 2013 - Seeking Alpha
10-Q: DELCATH SYSTEMS, INC. 4:49 p.m. Nov. 6, 2013 - Edgar Online - (EDG = 10Q, 10K)
Delcath Systems, Inc. Discusses Q3 2013 Results (Webcast) 4:25 p.m. Nov. 6, 2013 - Seeking Alpha
US Stock Futures Up Ahead Of Fed Speakers 5:24 a.m. Oct. 4, 2013 - benzinga.com
Delcath Systems Eliminates 33% of Workforce 4:33 a.m. Oct. 4, 2013 - benzinga.com
Hologic Scores Well in Brachtherapy Trial - Analyst Blog 4:40 p.m. Oct. 3, 2013 - Zacks.com
MAKO Buys Partner, Shares Hit 52-Week High - Analyst Blog 1:50 p.m. Oct. 3, 2013 - Zacks.com
Varian Unveils New Oncology Software - Analyst Blog 6:23 p.m. Sept. 25, 2013 - Zacks.com
Intuitive Surgical's Firefly Gets FDA Approval - Analyst Blog 2:30 p.m. Sept. 24, 2013 - Zacks.com
ARAY Platform Gains Foothold - Analyst Blog 3:35 p.m. Sept. 23, 2013 - Zacks.com
Radiosurgery Suite Boosts Varian Medical - Analyst Blog 2:20 p.m. Sept. 23, 2013 - Zacks.com
Thoratec Upped to Neutral - Analyst Blog 2:30 p.m. Sept. 20, 2013 - Zacks.com
PerkinElmer Upgraded to Neutral - Analyst Blog 1:40 p.m. Sept. 19, 2013 - Zacks.com
Moody's Changes Outlook of Fresenius - Analyst Blog 1:50 p.m. Sept. 18, 2013 - Zacks.com
Rochester General Gets MASI's Patient SafetyNet - Analyst Blog 1:50 p.m. Sept. 16, 2013 - Zacks.com
Delcath Board Implements Leadership Transition Plan 4:16 a.m. Sept. 13, 2013 - benzinga.com
Delcath Receives CRL from FDA for Melbleztm Kit NDA 4:15 a.m. Sept. 13, 2013 - benzinga.com
Delcath Systems Management Discusses Q2 2013 Results - Earnings Call Transcript 6:50 p.m. Aug. 6, 2013 - Seeking Alpha

Quick Market Round-up before the Bell: Delcath Systems, Valeant Pharma Intl., BioMarin Pharma, and Insmed 8:00 a.m. Jan. 9, 2014 - PR Newswire
DELCATH ANNOUNCES EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ'S MINIMUM BID PRICE RULE 6:31 a.m. Dec. 13, 2013 - Thomson Reuters ONE
Daily Trends Scanner: BioMarin Pharma Inc., Delcath Systems Inc., Akorn Inc., and Insmed Inc. 10:19 a.m. Dec. 11, 2013 - PR Newswire
Pre-Market Review: Delcath Systems Inc., BioMarin Pharma Inc., Insmed Inc., and Akorn Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Delcath Reports 2013 Third Quarter Results 4:05 p.m. Nov. 6, 2013 - PR Newswire
Pre-Market Analysis: BioMarin Pharma Inc., Insmed Inc., Delcath Systems Inc., and Akorn Inc. 10:34 a.m. Oct. 25, 2013 - PR Newswire
DELCATH TO RAISE APPROXIMATELY $7.5 MILLION 7:47 a.m. Oct. 23, 2013 - Thomson Reuters ONE
DELCATH TO REPORT THIRD QUARTER 2013 RESULTS ON NOVEMBER 6, 2013 9:46 a.m. Oct. 11, 2013 - Thomson Reuters ONE
Changes in Senior Management, Grants of Orphan Drug Designations, and Updates on Pipeline Development and NDA - Research Report on Vivus, Omeros, Delcath Systems, Achillion, and Zogenix 7:00 a.m. Oct. 7, 2013 - PR Newswire
DELCATH SYSTEMS ANNOUNCES STRATEGIC REORGANZATION 5:31 a.m. Oct. 4, 2013 - Thomson Reuters ONE
U.S. FDA GRANTS ORPHAN DRUG DESIGNATION TO DELCATH SYSTEMS FOR USE OF MELPHALAN HYDROCHLORIDE IN HCC 3:22 p.m. Oct. 1, 2013 - Thomson Reuters ONE
Today's Research: Astex Pharma Inc., Delcath Systems Inc., BioMarin Pharma Inc., and Akorn Inc. 7:09 a.m. Sept. 30, 2013 - PR Newswire
Five Star Equities Issues New Research Reports on DCTH, GALE, MKTO and NSPH 7:40 a.m. Sept. 16, 2013 - ACCESSWIRE
DELCATH SYSTEMS BOARD OF DIRECTORS IMPLEMENTS LEADERSHIP TRANSITION PLAN 5:06 a.m. Sept. 13, 2013 - Thomson Reuters ONE
DELCATH RECEIVES COMPLETE RESPONSE LETTER FROM FDA FOR MELBLEZTM KIT NEW DRUG APPLICATION 5:01 a.m. Sept. 13, 2013 - Thomson Reuters ONE
Pre-Market Review: Delcath Systems Inc., Astex Pharma Inc., BioMarin Pharma Inc., and Akorn Inc. 11:38 a.m. Aug. 21, 2013 - PR Newswire
DELCATH TO PRESENT AT WEDBUSH LIFE SCIENCES MANAGEMENT ACCESS CONFERENCE ON AUGUST 13, 2013 3:03 p.m. Aug. 7, 2013 - Thomson Reuters ONE
DELCATH REPORTS 2013 SECOND QUARTER RESULTS 3:21 p.m. Aug. 6, 2013 - Thomson Reuters ONE
Tuesday's Biotech Watch List - Alliqua, BioCryst Pharmaceuticals, Trovagene, Delcath Systems, Array BioPharma 8:00 a.m. July 23, 2013 - PR Newswire
DELCATH TO REPORT SECOND QUARTER 2013 RESULTS ON AUGUST 6, 2013 5:31 a.m. July 22, 2013 - Thomson Reuters ONE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

KINGRVER Boosts RV Comfort with New Water Heater Lineup

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...